Crestal bone preservation through the PREVAIL implant’s integrated platform-switching feature optimizes patient aesthetics with as little as 0.37 mm of bone recession and 50% reduction in crestal bone remodeling versus nonplatform-switched implants. Its unique Certain Internal Connection design provides higher seal strength as compared to the competitive average. It has enhanced osseointegration with OSSEOTITE and NanoTite PREVAIL Implants and 2 implant systems designed for primary stability with surface topographies targeting bone apposition and early healing. Additionally, research shows peri-implantitis risk mitigation with the OSSEOTITE surface. For more information, call (800) 342-5454 or visit the Web site biomet3i.com.